共 50 条
- [31] Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell LymphomaJOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08) : 613 - +O'Connor, Owen A.Ozcan, MuhitJacobsen, Eric D.Roncero, Josep M.Trotman, JudithDemeter, JuditMasszi, TamasPereira, JulianaRamchandren, RadhakrishnanBeaven, AnneCaballero, DoloresHorwitz, Steven M.Lennard, AnneTurgut, MehmetHamerschlak, Nelsond'Amore, Francesco A.Foss, FrancineKim, Won-SeogLeonard, John P.Zinzani, Pier LuigiChiattone, Carlos S.Hsi, Eric D.Truemper, LorenzLiu, HuaSheldon-Waniga, EmilyUllmann, Claudio DanskyVenkatakrishnan, KarthikLeonard, E. JaneShustov, Andrei R.
- [32] Hemophagocytosis and relapsed peripheral T-cell lymphomaEUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 82 (03) : 246 - 246Gallipoli, P.Drummond, M.Leach, M.
- [33] Gemcitabine, oxaliplatin and dexamethasone as salvage treatment for elderly patients with refractory and relapsed peripheral T-cell lymphomaLEUKEMIA & LYMPHOMA, 2013, 54 (06) : 1194 - 1200Yao, Yi-yunTang, YongZhu, QiZhuang, YanCheng, Yi-minWang, LeiZou, Li-fang
- [34] The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphomaBRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (05) : 750 - 758Chihara, DaiFanale, Michelle A.Miranda, Roberto N.Noorani, MansoorWestin, Jason R.Nastoupil, Loretta J.Hagemeister, Fredrick B.Fayad, Luis E.Romaguera, Jorge E.Samaniego, FelipeTurturro, FrancescoLee, Hun J.Neelapu, Sattva S.Rodriguez, M. AlmaWang, MichaelFowler, Nathan H.Davis, Richard E.Medeiros, L. JeffreyHosing, ChitraNieto, Yago L.Oki, Yasuhiro
- [35] Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: phase IIb resultsHAEMATOLOGICA, 2023, 108 (03) : 811 - 821Rai, ShinyaKim, Won SeogAndo, KiyoshiChoi, IlseungIzutsu, KojiTsukamoto, NorifumiYokoyama, MasahiroTsukasaki, KunihiroKuroda, JunyaAndo, JunHidaka, MichihiroKoh, YoungilShibayama, HirohikoUchida, ToshikiYang, Deok HwanIshitsuka, KenjiIshizawa, KenichiKim, Jin SeokLee, Hong GhiMinami, HironobuEom, Hyeon SeokKurosawa, MitsutoshiLee, Jae HoonLee, Jong SeokLee, Won SikNagai, HirokazuShindo, TakeroYoon, Dok HyunYoshida, ShinichiroGillings, MireilleOnogi, HiroshiTobinai, Kensei
- [36] Final Results from a Phase 2 Study of Tipifarnib in Subjects with Relapsed or Refractory Peripheral T-Cell LymphomaBLOOD, 2021, 138Witzig, Thomas E.Sokol, LubomirKim, Won Seogde la Cruz Vicente, FatimaCaballero, DoloresAdvani, Ranjanade Ona, RaquelMarin Niebla, AnaJose Terol, MariaDomenech Eva, DomingoBendris, NawalMackey Ahsan, JulieLeoni, MollieFoss, Francine M.
- [37] Analysis of Patients with Common Peripheral T-Cell Lymphoma Subtypes From a Phase 2 Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell LymphomaBLOOD, 2011, 118 (21) : 272 - 272Coiffier, BertrandPro, BarbaraPrince, H. MilesFoss, Francine M.Sokol, LubomirGreenwood, MatthewCaballero, DoloresBorchmann, PeterMorschhauser, FranckWilhelm, MartinPinter-Brown, LaurenPadmanabhan, SwaminathanShustov, Andrei R.Nichols, JeanCarroll, SusanBalser, JohnHorwitz, Steven M.
- [38] Golidocitinib favorable for relapsed/refractory T-cell lymphomaCANCER, 2024, 130 (08) : 1191 - 1192Nierengarten, Mary Beth
- [39] PHASE II STUDY OF SMILE CHEMOTHERAPY FOR RELAPSED/ REFRACTORY PERIPHERAL T-CELL LYMPHOMAHAEMATOLOGICA, 2015, 100 : 401 - 401Suzuki, R.Hyo, R.Kim, W. S.Tsukamoto, N.Maeda, Y.Masaki, Y.Sakai, R.Masunari, T.Niitsu, N.Ishida, F.Nakamura, S.Suzumiya, J.
- [40] A Phase II Study of Nivolumab in Patients with Relapsed or Refractory Peripheral T-Cell LymphomaBLOOD, 2019, 134Bennani, N. NoraPederson, Levi D.Atherton, PamelaMicallef, IvanaColgan, Joseph P.Thanarajasingam, GitaNowakowski, GrzegorzWitzig, Thomas E.Feldman, Andrew L.Ansell, Stephen M.